Body composition can be vastly different among people once thought to be similar, and it varies as we age and throughout stages of various diseases. Fat distribution and muscle quantity and quality can influence how patients respond to a treatment—making objective and accurate body composition measurements critical for ensuring best-possible patient outcomes.
Specific patterns of fat distribution are linked to metabolic disease, specifically the presence of coronary heart disease and type 2 diabetes.
Our main areas of focus in metabolic research include:
Neuromuscular disorders slowly progress and affect each individual differently, making it difficult to assess drug efficacy quickly and accurately. To assess muscles, NMD clinical studies often involve functional tests, such as the 6-minute walk test. However, these tests are slow to demonstrate the effect of a drug candidate and are often subjective—requiring longer studies and larger sample sizes.
By accurately and comprehensively assessing numerous muscles within an individual, you can detect small changes over time to better evaluate the impact of a drug candidate or analyze complex disease processes.
Core areas of neuromuscular disorder research:
With AMRA’s technology platform, MRI can be employed in a muscle-specific and disease-specific fashion. Our MRI method is more precise and comprehensive compared to conventional body composition methods, such as DXA and single-slice imaging, giving clinicians and researchers rich data they can trust.
Learn more about our technology or explore how AMRA’s technology can enhance clinical care and clinical research.